![\"Northrop](\"https:\/\/images-assets.nasa.gov\/image\/iss075e0189493\/iss075e0189493~large.jpg?w=1920&h=1078&fit=clip&crop=faces%2Cfocalpoint\")
<\/a><\/figure>Media accreditation is open for the next launch to deliver NASA science investigations, supplies, and equipment to the International Space Station. A Northrop Grumman Cygnus XL spacecraft will launch in November to the orbital laboratory on a SpaceX Falcon 9 rocket for NASA.<\/p>\n
The mission is known as NASA\u2019s Northrop Grumman Commercial Resupply Services 25, or NASA\u2019s Northrop Grumman CRS-25. Liftoff is targeted for no earlier than 10:49 a.m. EST, Sunday, Nov. 29, from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida.<\/p>\n
Following launch, astronauts aboard the space station will use the Canadarm2 robotic arm to capture Cygnus and install the spacecraft to the Unity module\u2019s Earth-facing port for cargo unloading. The spacecraft will remain at the space station until May 2027. This is the company\u2019s 25th spacecraft built to deliver supplies to the International Space Station under contract with NASA.<\/p>\n
Credentialing to cover prelaunch and launch activities is open to U.S. media. The application deadline for U.S. citizens is 11:59 p.m. EST, Thursday, Nov. 12. All accreditation requests must be submitted online at:<\/p>\n
https:\/\/media.ksc.nasa.gov<\/a><\/p>\n Credentialed media will receive a confirmation email following approval. NASA\u2019s media accreditation policy<\/a> is available online. For questions about accreditation, or to request special logistical support, email: ksc-media-accreditat@mail.nasa.gov.<\/a> For other questions, please contact NASA\u2019s Kennedy Space Center newsroom at: 321-867-2468.<\/p>\n In addition to food, supplies, and equipment for the crew, Cygnus will deliver several new experiments, including hardware to manufacture tiny, DNA-inspired particles<\/a> in space that could improve drug delivery for cancer and osteoarthritis, as well as a study that could guide cancer treatments<\/a> by predicting whether a patient\u2019s cancer is likely to spread to other parts of the body. Cygnus also will carry human muscle cells<\/a> and medications to test therapeutics for muscle loss associated with spaceflight and aging on Earth, and a compact radiation sensor<\/a> designed to improve crew safety on future missions.\u00a0<\/p>\n Each resupply mission to the station delivers scientific investigations in the areas of biology and biotechnology, Earth and space science, physical sciences, and technology development and demonstrations. Cargo resupply from U.S. companies ensures a national capability to deliver scientific research to the space station, increasing NASA\u2019s ability to conduct new investigations aboard humanity\u2019s laboratory in space.<\/p>\n For 26 years, people have lived and worked continuously aboard the International Space Station, advancing scientific knowledge and making research breakthroughs that are not possible on Earth. The space station is an important testbed for NASA to understand and overcome the challenges of long-duration spaceflight and to expand commercial opportunities in low Earth orbit. As commercial companies concentrate on providing human space transportation services and destinations as part of a strong low Earth orbit economy<\/a>, NASA is focusing its resources on deep space missions to the Moon as part of the Artemis and Moon Base programs to build on our foundation for the first astronaut missions to Mars.<\/p>\n Learn more about International Space Station research and operations at:<\/p>\n https:\/\/www.nasa.gov\/station<\/strong><\/a><\/p>\n -end-<\/p>\n Josh Finch \/ Jimi Russell Steven Siceloff Sandra Jones \/ Leah Cheshier
Headquarters, Washington
202-358-1100
joshua.a.finch@nasa.gov<\/a> \/ james.j.russell@nasa.gov<\/a><\/p>\n
Kennedy Space Center, Fla.
321-876-2468
steven.p.siceloff@nasa.gov<\/a><\/p>\n
Johnson Space Center, Houston
281-483-5111
sandra.p.jones@nasa.gov<\/a> \/ leah.d.cheshier@nasa.gov<\/a><\/p>\nShare<\/h2>\n<\/p><\/div>\n